Target intelligence / Profile preview

TIAM1 antisense RNA 1 (TIAM1-AS1)

Target
TIAM1-AS1
Molecular classification
Long non-coding RNA, Antisense RNA, Non-coding RNA
01

Overview

TIAM1 antisense RNA 1 (TIAM1-AS1) is a long non-coding RNA that is transcribed from the antisense strand of the TIAM1 genomic locus. Unlike the TIAM1 protein-coding gene, which has established roles in cancer, cytoskeletal remodeling, and cell migration, the specific biological functions and disease relevance of TIAM1-AS1 remain largely undetermined in the scientific literature as of 2024. Long non-coding RNAs like TIAM1-AS1 are known in general to modulate gene expression via RNA-RNA interactions, chromatin remodeling, or recruitment of regulatory protein complexes, often through antisense effects on neighboring genes. However, direct experimental evidence for such roles for TIAM1-AS1 is lacking in current databases and primary literature. There are no approved drugs that specifically target TIAM1-AS1, nor is it established as a biomarker or contributor to a defined disease process. If you are searching for information on the TIAM1 gene/protein itself, which is a well-established therapeutic target and a guanine nucleotide exchange factor (GEF) involved in cancer cell invasion, migration, and neurological processes, please specify, as the evidence and structured fields differ substantially.

Other names
TIAM1-AS1
02

Biological functions

Regulation of gene expression (potentially of TIAM1 or nearby genes)Possible involvement in mRNA stability, chromatin modification, or transcriptional regulation
03

Disease associations

Other

Beyond the preview

Go deeper on TIAM1 antisense RNA 1 (TIAM1-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on TIAM1 antisense RNA 1 (TIAM1-AS1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call